RELX Group has published a new analysis, conducted by Elsevier, on SDG3: Good health and wellbeing. Looking specifically at SDG 3, this graphic provides insight into peer-reviewed research on health and three intersection with three critical health and wellbeing research areas: non-communicable disease, gender equity and climate change.
, Chem, Volume 4, 13 September 2018
In 2007, John Warner and Jim Babcock founded the Warner Babcock Institute for Green Chemistry and, with Amy Cannon, founded the green chemistry education nonprofit organization Beyond Benign. John is the recipient of the 2004 Presidential Award for Excellence in Science Mentoring and the 2014 Perkin Medal. In addition, John is one of the founders of the field of green chemistry and is co-author of the defining textbook Green Chemistry: Theory and Practice.
In collaboration with the journal World Development, this international conference on Sustainability and Development seeks to bring together a diverse and interdisciplinary constituency to engage with the best approaches and means to implement the Sustainable Development Goals and assess progress towards them.
This article highlights the winning proposals of the third edition of the Elsevier Foundation Green & Sustainable Chemistry Challenge. The winning proposals were chosen for their innovative green chemistry aspects and their large positive impact on the environment, contributing to SDGs 2, 12, 13 and 15.
Elsevier Connect, 27 March 2018
Supports Goals 4 and 10. A unique partnership between the Next Einstein Forum (NEF) and Elsevier will see the creation of a new pan-African, peer reviewed, open access publishing journal, dedicated to boosting the global reach and impact of research by Africans.
The SDGs are all connected. Success in one goal often relies on success in another. The science supporting the SDGs needs to reflect these connections, which is what the Perspectives Project aims to achieve: enabling collaboration between experts from all over the world. The project addresses a core question: how is the SDG agenda influencing scholarly debates in different research areas, and vice-versa? The reviews will cover the breadth of the SDGs and will be published as part of three special issues in three key journals.
, Journal of Ethnopharmacology, Volume 210, 10 January 2018
Ethnopharmacological relevance In the Peruvian Amazon, the use of medicinal plants is a common practice. However, there is few documented information about the practical aspects of their use and few scientific validation. The starting point for this work was a set of interviews of people living in rural communities from the Peruvian Amazon about their uses of plants. Protozoan diseases are a public health issue in the Amazonian communities, who partly cope with it by using traditional remedies.
, The Lancet HIV, Volume 4, December 2017
Background Multistage, stepwise HIV testing and treatment procedures can result in lost opportunities to provide timely antiretroviral therapy (ART). Incomplete engagement of patients along the care cascade translates into high preventable mortality. We aimed to identify whether a structural intervention to streamline testing and linkage to HIV health care would improve testing completeness, ART initiation, and viral suppression and reduce mortality. Methods We did a cluster-randomised, controlled trial in 12 hospitals in Guangxi, China.
Elsevier Connect, Nov 3 2017
A fundamental shift in how cancer research is conducted and how cancer care is delivered in the United States is required in order to deliver on the Cancer Moonshot initiative, according to a major new report called The Lancet Oncology Commission: Future Research Priorities in the USA. Authored by over 50 leading oncologists, including members of leading US cancer organizations, the report sets out 13 key priority areas, each with measurable goals, to focus the $2 billion of funding released to the National Cancer Institute (NCI) as part of the 21st Century Cures Act.
Lancet Oncology Commission, November 2017
The report is authored by over 50 leading oncologists, including members of leading US cancer organizations, and sets out 13 key priority areas, each with measurable goals, to focus the $2 billion of funding released to the National Cancer Institute (NCI) as part of the 21st Century Cures Act. The report sets out a detailed road map to deliver on the Blue Ribbon Panel recommendations, including a focus on prevention, a new model for drug discovery and development, a vast expansion of patient access to clinical trials, and an emphasis on targeted interventions to improve cancer care for underserved groups, specifically children, cancer survivors and minority groups.